What is NDC 0093-2180?

0093-2180 is the product NDC for Liothyronine Sodium, Liothyronine sodium 50 ug/1 tablet, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Liothyronine Sodium?

44 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Liothyronine Sodium NDC 0093-2180 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-2180Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-2180Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-2180-01	00093218001	100 TABLET in 1 BOTTLE (0093-2180-01)Marketed from Feb 26, 2021

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Liothyronine Sodium
Generic name (nonproprietary): liothyronine sodium
Active ingredients: Liothyronine sodium — 50 ug/1
Dosage form: Tablet
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.NDC labeler code 0093
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211510
Marketing start: Feb 26, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Triiodothyronine (Chemical structure)
Identifiers: Product ID 0093-2180_5a80850c-0302-4dc1-a1e3-06d21dec53aaSPL ID 5a80850c-0302-4dc1-a1e3-06d21dec53aaSPL set ID 548d684a-86f5-4e57-9844-d8cf0a84e068RxCUI 903456, 903697, 903703UNII GCA9VV7D2NUPC 0300932178014, 0300932180017
Pharmacologic class: l-Triiodothyronine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093218001 followed by a unit qualifier and the quantity

Package 00093-2180-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 1, 2020. This label includes a boxed warning.

Indications (excerpt from the label)

Liothyronine sodium is an L-triiodothyronine (T3) indicated for: Hypothyroidism: As replacement in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism ( 1.1 ) Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer ( 1.2 ) Thyroid Suppression Test: As a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy ( 1.3 ) Limitations of Use: - Not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients. ( 1 ) - Not …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0093-2180

What is NDC 0093-2180?: 0093-2180 is the product NDC for Liothyronine Sodium, Liothyronine sodium 50 ug/1 tablet, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Liothyronine Sodium.
What is the active ingredient?: Liothyronine sodium.
Who is the labeler?: Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Liothyronine Sodium?: 44 other product NDCs are listed under this name. See all Liothyronine Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Liothyronine Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Liothyronine Sodium	Liothyronine sodium 25 ug/1	TabletOral	Dr. Reddy's Labratories Inc.	75907-001	75907-0001-01
Liothyronine Sodium	Liothyronine sodium 50 ug/1	TabletOral	Dr. Reddy's Labratories Inc.	75907-004	75907-0004-01
Liothyronine Sodium	Liothyronine sodium 5 ug/1	TabletOral	Dr. Reddy's Labratories Inc.	75907-039	75907-0039-01
Liothyronine sodium	Liothyronine sodium 5 ug/1	TabletOral	Biocon Pharma Inc.	70377-114	70377-0114-1170377-0114-1270377-0114-13
Liothyronine sodium	Liothyronine sodium 25 ug/1	TabletOral	Biocon Pharma Inc.	70377-115	70377-0115-1170377-0115-1270377-0115-13
Liothyronine sodium	Liothyronine sodium 50 ug/1	TabletOral	Biocon Pharma Inc.	70377-116	70377-0116-1170377-0116-1270377-0116-13
Liothyronine sodium	Liothyronine sodium 5 ug/1	TabletOral	Northstar Rx LLC	16714-166	16714-0166-01
Liothyronine sodium	Liothyronine sodium 25 ug/1	TabletOral	Northstar Rx LLC	16714-167	16714-0167-01
Liothyronine sodium	Liothyronine sodium 50 ug/1	TabletOral	Northstar Rx LLC	16714-168	16714-0168-01
Liothyronine Sodium	Liothyronine sodium 25 ug/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-2178	00093-2178-01

All 45 Liothyronine Sodium NDCs

Other NDCs under ANDA 211510

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211510
Product	Strength	Form · route	Labeler	Product NDC
Liothyronine Sodium	Liothyronine sodium 25 ug/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-2178
Liothyronine Sodium	Liothyronine sodium 5 ug/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-2179